olanzapine and fluoxetine

Generic: olanzapine and fluoxetine

Labeler: teva pharmaceuticals usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name olanzapine and fluoxetine
Generic Name olanzapine and fluoxetine
Labeler teva pharmaceuticals usa, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

fluoxetine hydrochloride 50 mg/1, olanzapine 12 mg/1

Manufacturer
Teva Pharmaceuticals USA, Inc.

Identifiers & Regulatory

Product NDC 0093-5507
Product ID 0093-5507_49dfc18c-9d68-4489-83f5-d59bb2596b80
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077528
Listing Expiration 2026-12-31
Marketing Start 2012-06-19

Pharmacologic Class

Established (EPC)
atypical antipsychotic [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00935507
Hyphenated Format 0093-5507

Supplemental Identifiers

RxCUI
403969 403970 403971 403972 721787
UPC
0300935506562 0300935503561 0300935505565 0300935507569 0300935504568
UNII
N7U69T4SZR I9W7N6B1KJ
NUI
N0000175430

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name olanzapine and fluoxetine (source: ndc)
Generic Name olanzapine and fluoxetine (source: ndc)
Application Number ANDA077528 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
  • 12 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE (0093-5507-56)
source: ndc

Packages (1)

Ingredients (2)

fluoxetine hydrochloride (50 mg/1) olanzapine (12 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "49dfc18c-9d68-4489-83f5-d59bb2596b80", "openfda": {"nui": ["N0000175430"], "upc": ["0300935506562", "0300935503561", "0300935505565", "0300935507569", "0300935504568"], "unii": ["N7U69T4SZR", "I9W7N6B1KJ"], "rxcui": ["403969", "403970", "403971", "403972", "721787"], "spl_set_id": ["3c28cf18-01a3-468a-ab3e-8aa82f918251"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (0093-5507-56)", "package_ndc": "0093-5507-56", "marketing_start_date": "20120619"}], "brand_name": "Olanzapine and Fluoxetine", "product_id": "0093-5507_49dfc18c-9d68-4489-83f5-d59bb2596b80", "dosage_form": "CAPSULE", "pharm_class": ["Atypical Antipsychotic [EPC]", "Serotonin Reuptake Inhibitor [EPC]", "Serotonin Uptake Inhibitors [MoA]"], "product_ndc": "0093-5507", "generic_name": "Olanzapine and Fluoxetine", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Olanzapine and Fluoxetine", "active_ingredients": [{"name": "FLUOXETINE HYDROCHLORIDE", "strength": "50 mg/1"}, {"name": "OLANZAPINE", "strength": "12 mg/1"}], "application_number": "ANDA077528", "marketing_category": "ANDA", "marketing_start_date": "20120619", "listing_expiration_date": "20261231"}